Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Trieu Vuong Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2023 4 Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.
Txns: Bought 425,000 shares @ $0.021, valued at $8.9k
Bought 75,000 shares @ $0.026, valued at $2k
06/16/2023 4 Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.
Txns: Bought 400,000 shares @ $0.0326, valued at $13k
05/31/2023 4 Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.
Txns: Bought 126,888 shares @ $0.0341, valued at $4.3k
05/02/2023 4 Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.
Txns: Bought 100,000 shares @ $0.045, valued at $4.5k
12/07/2022 4 Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.
Txns: Bought 120,000 shares @ $0.05, valued at $6k
11/25/2022 4 Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.
Txns: Bought 70,000 shares @ $0.08, valued at $5.6k
09/28/2022 4 Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.
Txns: Bought 20,000 shares @ $0.068, valued at $1.4k
08/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/16/2021 4 Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.
Txns: Converted 74,455,719 shares @ $0
Granted 259,302 shares @ $0
Converted 13,849,161 shares @ $0
Converted 5,672,025 shares @ $0
Converted 74,456 convertible preferred @ $0
Converted 13,849 convertible preferred @ $0
Converted 5,672 convertible preferred @ $0
Granted 513,953 options @ $0.1626, valued at $83.6k
11/23/2020 4 Trieu Vuong (CEO) has filed a Form 4 on MATEON THERAPEUTICS INC
Txns: Bought 50,500 shares @ $0.19, valued at $9.6k
03/27/2020 4 Trieu Vuong (CEO) has filed a Form 4 on MATEON THERAPEUTICS INC
Txns: Bought 3,000 shares @ $0.12, valued at $360
05/02/2019 3 Trieu Vuong (CEO and Chairman of the Board) has filed a Form 3 on MATEON THERAPEUTICS INC
10/04/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2018 4 Trieu Vuong (Executive Chairman) has filed a Form 4 on Marina Biotech, Inc.
Txns: Granted 2 convertible preferred @ $0.5, valued at $1.1
Granted 16,875 options to buy @ $0.55, valued at $9.3k
Converted 35 convertible preferred @ $0.5, valued at $17.3
Converted 258,825 options to buy @ $0.55, valued at $142.4k
Converted convertible notes @ $5000, valued at $0
Converted 115 convertible preferred @ $0.5, valued at $57.3
Converted 859,725 options to buy @ $0.55, valued at $472.8k
Converted options to buy @ $5000, valued at $0
Converted 19 convertible preferred @ $0.5, valued at $9.5
Converted 142,500 options to buy @ $0.55, valued at $78.4k
Converted options to buy @ $5000, valued at $0
01/03/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/12/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/08/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/08/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
11/23/2016 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
11/22/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/22/2016 3 Form 3 - Initial statement of beneficial ownership of securities
10/31/2013 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy